Cryoglobulinemia: An update in 2019.
Desbois AC, Cacoub P, Saadoun D.
Joint Bone Spine. 2019 Nov;86(6):707-713. doi: 10.1016/j.jbspin.2019.01.016. Epub 2019 Feb 4.
Membranoproliferative glomerulonephritis.
Alchi B, Jayne D.
Pediatr Nephrol. 2010 Aug;25(8):1409-18. doi: 10.1007/s00467-009-1322-7. Epub 2009 Nov 12.
Proliferative glomerulonephritis with monoclonal immunoglobulin deposits: a nephrologist perspective.
Bridoux F, Javaugue V, Nasr SH, Leung N.
Nephrol Dial Transplant. 2021 Jan 25;36(2):208-215. doi: 10.1093/ndt/gfz176.
Membranoproliferative glomerulonephritis: no longer the same disease and may need very different treatment.
Noris M, Daina E, Remuzzi G.
Nephrol Dial Transplant. 2023 Feb 13;38(2):283-290. doi: 10.1093/ndt/gfab281.
Challenges in the Diagnosis and Management of Immune Complex-Mediated Membranoproliferative Glomerulonephritis and Complement 3 Glomerulopathy.
Bomback AS, Charu V, Fakhouri F.
Kidney Int Rep. 2024 Sep 21;10(1):17-28. doi: 10.1016/j.ekir.2024.09.017. eCollection 2025 Jan.
Mixed cryoglobulinemia.
Ferri C.
Orphanet J Rare Dis. 2008 Sep 16;3:25. doi: 10.1186/1750-1172-3-25.
Acute glomerulonephritis.
Vinen CS, Oliveira DB.
Postgrad Med J. 2003 Apr;79(930):206-13; quiz 212-3. doi: 10.1136/pmj.79.930.206.
SLC37A4-CDG: Second patient.
Wilson MP, Quelhas D, Leão-Teles E, Sturiale L, Rymen D, Keldermans L, Race V, Souche E, Rodrigues E, Campos T, Van Schaftingen E, Foulquier F, Garozzo D, Matthijs G, Jaeken J.
JIMD Rep. 2021 Jan 6;58(1):122-128. doi: 10.1002/jmd2.12195. eCollection 2021 Mar.
Bedeutung und Management der Rezidive von Glomerulonephritiden im Nierentransplantat.
Marti HP, Dörje C, Strøm EH.
Ther Umsch. 2015 Mar;72(3):199-206. doi: 10.1024/0040-5930/a000665.
Type I membranoproliferative glomerulonephritis and HCV infection.
Rostoker G, Pawlotsky JM, Bastie A, Weil B, Dhumeaux D.
Nephrol Dial Transplant. 1996;11 Suppl 4:22-4. doi: 10.1093/ndt/11.supp4.22.
